4.8 Article

Hollow structured upconversion luminescent NaYF4:Yb3+, Er3+ nanospheres for cell imaging and targeted anti-cancer drug delivery

Journal

BIOMATERIALS
Volume 34, Issue 5, Pages 1601-1612

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2012.11.004

Keywords

Hollow structure; NaYF4; Upconversion; Drug delivery; Cell imaging

Funding

  1. National Basic Research Program of China [2010CB327704]
  2. National High Technology Program of China [2011AA03A407]
  3. National Natural Science Foundation of China [NSFC 51172228, 51272248, 20901074, 20921002]
  4. Science Technology Development Program of Jilin Province for Youths [20100106]

Ask authors/readers for more resources

Uniform alpha-NaYF4:Yb3+, Er3+ nanospheres (similar to 130 nm) with mesoporous shell and hollow interior structure were synthesized by using Y(OH)CO3:Yb3+, Er3+ nanospheres (NPs) as sacrificial templates via a surface-protected etching and hydrothermal ion-exchange process. In this process, polyethylenimine (PEI) ligands played a key role in formation of the hollow structured alpha-NaYF4 nanospheres, i.e., they can effectively protect the surface of the Y(OH)CO3 from rapid dissolution by H+. Moreover, folic acid (FA), a commonly used cancer-targeting agent was conjugated on the surface of NPs based on the presence of free amine groups. The as-prepared FA-modified hollow NPs can be performed as anti-cancer drug carriers for the investigation of drug storage/release properties, which exhibit greater cytotoxicity than DOX-loaded alpha-NaYF4 NPs due to the specific cell uptake by HeLa cells via FA receptor-mediate endocytosis. Furthermore, upconversion (UC) luminescence images of FA-modified alpha-NaYF4:Yb3+, Er3+ NPs uptaken by cells shows bright green emission without background noise under 980 nm infrared laser excitation. Thus, these multifunctional nanospheres combining UC luminescent property and hollow and mesoporous structure have potential for simultaneous targeted anti-cancer drug delivery and cell imaging. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available